RESULTS: There were no significant differences in micturition pressure, threshold pressure, voided volume, post-void residual, bladder capacity or voiding efficiency among 3 groups. The number of non-voiding contractions (NVCs) per a voiding cycle in groups B and C were significantly lower than that of group A. NGF levels of the bladder mucosa and spinal cord of SCI mice (group A) were significantly increased compared with spinal intact mice. Two-weeks (group C), but not one-week (group B), anti-NGF treatment significantly decreased bladder mucosal and spinal NGF expression. The mRNA levels of TRPA1 and TRPV1 were increased in SCI mice compared to spinal intact mice, and significantly decreased after both 1 week and 2 weeks of anti-NGF treatment.
INTRODUCTION AND OBJECTIVES: Many rats with chronic suprasacral spinal cord injury (SCI) demonstrate hind limb locomotor activity (HLLA) in response to external crede or high pressure contractions during cystometry. We propose that this aberrant, pressuredriven bladder reflex pathway may be harnessed to facilitate walking in SCI patients. As a first step in exploring this possibility, we examined the relationship between intravesical pressure (IVP) and HLLA in chronic suprasacral SCI rats.
METHODS: Female rats (4 weeks post-SCI at T9-10, n¼16) were anesthetized with isoflurane and fitted with transvesical catheters and right quadriceps EMG electrodes to monitor bladder and hind limb locomotor activities, respectively. The animals were mounted in Ballman restraint cages to which they had been previously acclimated. The catheter was connected to a pressure transducer, an infusion pump, and a saline-filled reservoir mounted on a metered vertical pole (pressure clamp). After 30 min of recovery from anesthesia, the bladder was filled at 0.1 ml/min with saline to verify bladder-to-bladder reflex activity for 30 min. IVP was then increased in an interrupted stepwise fashion from 0-120 cmH2O at 10 cmH2O increments. Each step consisted of five minutes: 3 minutes at the new pressure followed by 2 minutes at 0 cmH2O. IVP and the number of HLLA events (as defined by rhythmic EMG discharges of 3-10 cycles/event) were recorded for each pressure step. This process was repeated for two more trials for each rat to assess the durability of the reflex. Data were analyzed using ANOVA with repeated measures both within and across pressure escalation trials. P<0.05 was considered significant.
RESULTS: ANOVA revealed that locomotor events increased with increasing intravesical pressure and decreased with the number of escalation trials (P<0.0001 for both effects). The increase in the number of locomotor events with increasing intravesical pressure appeared to plateau at~50-60 cmH2O (P<0.05 for all). The average of the maximal number of locomotor events for each animal decreased steadily from~3.0, 2.5 and 1.75 over the three trials.
CONCLUSIONS: There is a positive relationship between IVP and HLLA that suggests the emergence of an aberrant bladder-to-hind limb locomotor reflex pathway following SCI. It may be possible to harness this reflex pathway independently of the state of the bladder to facilitate walking in SCI patients.
Source of Funding: This work was funded by a grant from the VA RRD SPiRE RX-001749-01
MP85-03 THE THERAPEUTIC EFFECT OF TRPV4 ACTIVATION IN THE BLADDER ON UNDERACTIVE BLADDER IN RATS WITH PELVIC NERVE CRUSH
Ei-ichiro Takaoka*, Shun Takai, Takahisa Suzuki, Nobutaka Shimizu, Joonbeom Kwon, Hiroki Okada, Pittsburgh, PA; Hiroyuki Nishiyama, Tsukuba, Japan; Naoki Yoshimura, Christopher J. Chermansky, Pittsburgh, PA INTRODUCTION AND OBJECTIVES: Incomplete bladder emptying due to detrusor underactivity (DU) is a significant urological problem underlying underactive bladder (UAB). Also, TRPV4 has been reported to be one of the mechanosensitive channels expressed in the bladder. In this study, we sought to produce a consistent rat model of UAB with the modification of our previous model of pelvic nerve crush (PNC) (2016 AUA) and evaluated the therapeutic effect of intravesical application of a TRPV4 agonist on the UAB condition.
METHODS: In female Sprague-Dawley rats, the visceral branches of bilateral pelvic nerves were identified near the internal iliac vessels and bilateral PNC was made by two times of nerve compression of either side with each 20-seconds duration using sharp forceps. After 10 days, awake cystometrograms (CMG) were recorded in sham control and PNC rats. Then, in both groups, a TRPV4 agonist (GSK1016790A) was continuously administered into the bladder and the CMG parameters were compared before and after intravesical drug administration.
RESULTS: The bladder weight was significantly increased in PNC rats vs. control rats. In CMG, PNC rats showed significant increases in voided volume, post-void residual urine volume, and residual urine rate compared to control rats. PNC rats also revealed the significant increases in intercontraction intervals (ICI), a number of nonvoiding contractions, and threshold pressure while the amplitude during voiding was significantly decreased (table). In the TRPV4 administration study, intravesical application of 1.5mM of GSK 1016790A significantly decreased ICI, voided volume, and post-void residual urine volume in PNC rats while it did not significantly affect any CMG parameters in control rats.
CONCLUSIONS: Rats with pelvic nerve injury induced by the modified PNC method, which showed the characteristics of DU, seem to be an appropriate model for evaluation of peripheral neurogenic mechanisms of UAB. Also TRPV4 that reduced the bladder capacity and residual urine volume could be a potential target for the treatment of UAB. 
INTRODUCTION AND OBJECTIVES:
A conus medullaris syndrome results from an Injury to the conus medullaris and cauda equine portions of the spinal cord. The clinical presentation is characterized by a lower motor neuron weakness affecting both skeletal muscles and pelvic organs with signs of paralysis, sensory disturbance and impairments of bladder, bowel, and sexual functions. The goal of the present study was to translate the unilateral lumbosacral ventral root avulsion (VRA) injury model from the rat to rhesus macaques, and to determine early and late effects of pelvic target denervation on lower urinary tract and external anal sphincter (EAS) function.
METHODS: A total of 6 female rhesus macaques were included. A unilateral L6-S3 VRA injury was performed and resulted in a lesion of all preganglionic parasympathetic fibers of the ipsilateral pelvic nerve and all somatic motor fibers of the ipsilateral pudendal nerve. Urodynamic studies and EAS electromyography (EMG) were performed under ketamine anesthesia in control subjects (n¼6), and at 1 month and 6 months after the unilateral VRA injury (n¼4).
RESULTS: The bladder infusion rate was between 85 and 120 mL/min to partially fill the bladder and induce reflex voiding. Poor voiding efficiency and compliance, and a slower urine flow rate were found in VRA subjects. The EAS guarding reflex was tested using a rectal probe. The maximum amplitude and area under the curve of EAS EMG were significantly decreased at 1 month after injury, but recovered at 6 months. Power spectrum (Fig. 1) showed that the peak frequency increased at 1 month after injury, but it was reduced to normal state at 6 month. The mean frequency was decreased at 1 and 6 months after injury. CONCLUSIONS: This model eliminated the parasympathetic fibers of pelvic nerve and the somatic motor fibers of pudendal nerve, which resulted in detrusor underactivity and poor EAS contractility. Power spectrum analysis indicated that fewer motor units fired during EAS contraction after injury. This model in rhesus macaques mimics the clinical phenotype of conus medullaris syndrome using a lumbosacral VRA injury approach in long-term studies. It may provide a useful model to test the utility of emerging treatments after denervation of pelvic targets. We recently characterized a murine model of coronavirus-induced encephalomyelitis (CIE model), and confirmed that CIE mice develop neurogenic bladder dysfunction that was comparable with neurogenic LUTS observed in MS patients. Identified mechanisms were morphological changes in the centers controlling micturition, spinal cord gliosis, and increased expression of pro-inflammatory cytokines. In the current study, we aimed to understand the long-term effects of neurodegenerative changes on micturition patterns and bladder physiology, as well as uncover the mechanisms of long-lasting neurogenic bladder dysfunction.
Source of
METHODS: Adult C57BL/6J mice were inoculated with 20 ml of mouse hepatitis virus (MHV, N¼44, CIE mice) or PBS (N¼19). Neurological symptoms and mouse weight were recorded daily, and voiding behavior weekly up to 8 wks pi. Neurologic symptoms were evaluated by the Clinical Symptoms Score (CSS) on a scale from 0 (asymptomatic) to 4 (quadriparesis/paralysis). Detrusor contractility was evaluated in vitro at 10 wks. Based on CSS, CIE mice were assigned to 2 groups: recovery (REC group), and relapse (RELAP group). RELAP group was defined based on: (1) presence of symptomfree period at least for 24 hrs after initial rise in CSS, (2) presence of 2 symptom-free periods (24 h duration each), and (3) CSS>2 during the relapse.
RESULTS: Long-term follow up of CIE mice revealed two different neurological phenotypes: 1-recovery from initial acute neurological impairment (REC, 73.5% of all CIE mice, N¼25); and 2-relapse in symptoms (RELAP, 26.5% of all CIE mice, N¼9). Eight percent of mice in REC group still had CSS!2 at 8 wks in comparison to 22.2% in RELAP group. Animals in both REC and RELAP groups showed the most significant weight loss at 1wk. (22.3AE0.28g at baseline vs 16.5AE0.3g in REC group, and 9.2AE0.86g in RELAP group, p<0.05). Isolated bladder strips from CIE mice did not have significant differences in muscarinic responses to EFS, however, RELAP group showed significantly decreased M3 responses along with increased micturition frequency at 5-6 wks.
